BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34529143)

  • 1. Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?
    Rivas-Santiago B; Jacobo-Delgado Y; Rodriguez-Carlos A
    Arch Immunol Ther Exp (Warsz); 2021 Sep; 69(1):25. PubMed ID: 34529143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
    Brown RE; Hunter RL
    Ann Clin Lab Sci; 2020 Mar; 50(2):287-288. PubMed ID: 32366572
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.
    Findlay F; Proudfoot L; Stevens C; Barlow PG
    Pathog Glob Health; 2016; 110(4-5):137-47. PubMed ID: 27315342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.
    Hilchie AL; Wuerth K; Hancock RE
    Nat Chem Biol; 2013 Dec; 9(12):761-8. PubMed ID: 24231617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional cationic host defence peptides and their clinical applications.
    Yeung AT; Gellatly SL; Hancock RE
    Cell Mol Life Sci; 2011 Jul; 68(13):2161-76. PubMed ID: 21573784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status could determine efficacy of COVID-19 therapies.
    Cully M
    Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
    [No Abstract]   [Full Text] [Related]  

  • 8. A molecular arms race between host innate antiviral response and emerging human coronaviruses.
    Wong LY; Lui PY; Jin DY
    Virol Sin; 2016 Feb; 31(1):12-23. PubMed ID: 26786772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the tree of life: Host defense peptides as antiviral therapeutics.
    Shartouny JR; Jacob J
    Semin Cell Dev Biol; 2019 Apr; 88():147-155. PubMed ID: 29524585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of small animal model hinders MERS coronavirus research.
    Devitt E
    Nat Med; 2013 Aug; 19(8):952. PubMed ID: 23921729
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19.
    Khalili JS; Zhu H; Mak NSA; Yan Y; Zhu Y
    J Med Virol; 2020 Jul; 92(7):740-746. PubMed ID: 32227493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronaviruses - drug discovery and therapeutic options.
    Zumla A; Chan JF; Azhar EI; Hui DS; Yuen KY
    Nat Rev Drug Discov; 2016 May; 15(5):327-47. PubMed ID: 26868298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MERS coronavirus has low pandemic potential, so far.
    BMJ; 2013 Jul; 347():f4371. PubMed ID: 23843549
    [No Abstract]   [Full Text] [Related]  

  • 16. Future treatment strategies for novel Middle East respiratory syndrome coronavirus infection.
    Adedeji AO; Sarafianos SG
    Future Med Chem; 2013 Dec; 5(18):2119-22. PubMed ID: 24261888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cationic antimicrobial peptides: from innate immunity study to drug development. Up date].
    Andrès E; Dimarcq JL
    Med Mal Infect; 2007 Apr; 37(4):194-9. PubMed ID: 17306486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host Defense Peptides: Dual Antimicrobial and Immunomodulatory Action.
    Drayton M; Deisinger JP; Ludwig KC; Raheem N; Müller A; Schneider T; Straus SK
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Peptides and Innate Lung Defenses: Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications.
    Hiemstra PS; Amatngalim GD; van der Does AM; Taube C
    Chest; 2016 Feb; 149(2):545-551. PubMed ID: 26502035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halting coronavirus polymerase.
    Kirchdoerfer RN
    J Biol Chem; 2020 Apr; 295(15):4780-4781. PubMed ID: 32277065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.